Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Bioequivalent Pharmaceutical Composition Of Vortioxetine Hydrobromide And One Or More Pharmaceutically Acceptable Excipients.
Abstract: The invention relates to Vortioxetine Hydrobromide having particle size distribution of D98 105—13511, D50 35—60}; and D5 7-10p as well as to a stable, reproducible and bioequivalent pharmaceutical composition comprising Vortioxetine Hydrobromide having particle size distribution of D98 105-13511, D50 35-6011 and D5 7-10p and one or more pharmaceutically acceptable excipient. It is produced by wet granulation techniques
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
17 February 2017
Publication Number
34/2018
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
ipm@unichemlabs.com
Parent Application
Applicants
UNICHEM LABORATORIES LTD
UNICHEM BHAVAN, PRABHAT ESTATE, S. V. ROAD, JOGESHWARI (WEST), MUMBAI-400 102, MAHARASHTRA, INDIA.
Inventors
1. MR. MILIND VINAYAK SATHE
LAXMI NIWAS CHS,FLAT NO 42 OFF SUBHASH ROAD PLOT NO 22,VILE PARLE(EAST) MUMBAI-400057,MAHARASHTRA INDIA.
2. MR SRIKANT V PIMPLE
B101,VASTUSHREE PEARL NEAR KINARA HOTEL,PAUD ROAD,KOTHRUD PUNE-411038,MAHARASHTRA INDIA.
3. MR PRAVIN KUMAR MAURYA
SURVEY NO.139/3 FLAT NO.112,1ST FLOOR AQUAMARINA SHINDE WASTI ROAD,BEHIND ESCON TEMPLE,RAVET,KIVALE PUNE-412101,MAHARASHTRA INDIA.
Specification
Documents
Orders
| Section | Controller | Decision Date |
|---|---|---|
| 15 & 25((1) | Miss Latika Dawara | 2024-04-23 |
| 15 & 25((1) | Miss Latika Dawara | 2024-04-23 |
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201721005626-ANY SUPPORTING DOCUMENT [23-04-2024(online)].pdf | 2024-04-23 |
| 1 | 201721005626-REQUEST FOR CERTIFIED COPY [30-03-2018(online)].pdf | 2018-03-30 |
| 2 | 201721005626-FORM-26 [03-04-2018(online)].pdf | 2018-04-03 |
| 2 | 201721005626-Written submissions and relevant documents [23-04-2024(online)].pdf | 2024-04-23 |
| 3 | 201721005626-CORRESPONDENCE(IPO)-(CERTIFIED COPY)-(05-04-2018).pdf | 2018-04-05 |
| 3 | 201721005626-Correspondence to notify the Controller [16-04-2024(online)].pdf | 2024-04-16 |
| 4 | 201721005626-FORM 3 [02-07-2018(online)].pdf | 2018-07-02 |
| 4 | 201721005626-Correspondence to notify the Controller [03-04-2024(online)].pdf | 2024-04-03 |
| 5 | 201721005626-Other Patent Document-170217.pdf | 2018-08-11 |
| 5 | 201721005626-FORM 13 [21-03-2024(online)].pdf | 2024-03-21 |
| 6 | 201721005626-POA [21-03-2024(online)].pdf | 2024-03-21 |
| 6 | 201721005626-Form 5-170217.pdf | 2018-08-11 |
| 7 | 201721005626-PreGrant-ExtendedHearingNotice-(HearingDate-19-04-2024).pdf | 2024-03-21 |
| 7 | 201721005626-Form 3-170217.pdf | 2018-08-11 |
| 8 | 201721005626-PreGrant-HearingNotice-(HearingDate-12-04-2024).pdf | 2023-11-16 |
| 8 | 201721005626-Form 2(Title Page)-170217.pdf | 2018-08-11 |
| 9 | 201721005626-Form 1-170217.pdf | 2018-08-11 |
| 9 | 201721005626-FORM 3 [11-10-2023(online)].pdf | 2023-10-11 |
| 10 | 201721005626-Correspondence-181217.pdf | 2018-08-11 |
| 10 | 201721005626-FORM 3 [29-04-2023(online)].pdf | 2023-04-29 |
| 11 | 201721005626- ORIGINAL UR 6( 1A) FORM 26-110418.pdf | 2018-08-11 |
| 11 | 201721005626-FORM 3 [01-11-2022(online)].pdf | 2022-11-01 |
| 12 | 201721005626-Correspondence-300719.pdf | 2019-08-01 |
| 12 | 201721005626-FORM 3 [03-05-2022(online)].pdf | 2022-05-03 |
| 13 | 201721005626-Correspondence--300719.pdf | 2019-08-01 |
| 13 | 201721005626-OTHERS [16-11-2021(online)].pdf | 2021-11-16 |
| 14 | 201721005626-FORM 3 [27-08-2019(online)].pdf | 2019-08-27 |
| 14 | 201721005626-PRE GRANT OPPOSITION DOCUMENT [16-11-2021(online)].pdf | 2021-11-16 |
| 15 | 201721005626-Form 3-040919.pdf | 2019-11-02 |
| 15 | 201721005626-PRE GRANT OPPOSITION FORM [16-11-2021(online)].pdf | 2021-11-16 |
| 16 | 201721005626-Form 3-010319.pdf | 2020-01-14 |
| 16 | 201721005626-Written submissions and relevant documents [12-11-2021(online)].pdf | 2021-11-12 |
| 17 | 201721005626-FORM 3 [25-02-2020(online)].pdf | 2020-02-25 |
| 17 | 201721005626-Correspondence to notify the Controller [08-11-2021(online)].pdf | 2021-11-08 |
| 18 | 201721005626-FORM 13 [29-10-2021(online)].pdf | 2021-10-29 |
| 18 | 201721005626-FORM 3 [28-07-2020(online)].pdf | 2020-07-28 |
| 19 | 201721005626-FER.pdf | 2021-10-18 |
| 19 | 201721005626-FORM 18 [29-01-2021(online)].pdf | 2021-01-29 |
| 20 | 201721005626-FORM 3 [23-02-2021(online)].pdf | 2021-02-23 |
| 20 | 201721005626-US(14)-HearingNotice-(HearingDate-10-11-2021).pdf | 2021-10-18 |
| 21 | 201721005626-FER_SER_REPLY [20-09-2021(online)].pdf | 2021-09-20 |
| 21 | 201721005626-US(14)-HearingNotice-(HearingDate-16-11-2021).pdf | 2021-10-18 |
| 22 | 201721005626-FER_SER_REPLY [20-09-2021(online)].pdf | 2021-09-20 |
| 22 | 201721005626-US(14)-HearingNotice-(HearingDate-16-11-2021).pdf | 2021-10-18 |
| 23 | 201721005626-FORM 3 [23-02-2021(online)].pdf | 2021-02-23 |
| 23 | 201721005626-US(14)-HearingNotice-(HearingDate-10-11-2021).pdf | 2021-10-18 |
| 24 | 201721005626-FORM 18 [29-01-2021(online)].pdf | 2021-01-29 |
| 24 | 201721005626-FER.pdf | 2021-10-18 |
| 25 | 201721005626-FORM 13 [29-10-2021(online)].pdf | 2021-10-29 |
| 25 | 201721005626-FORM 3 [28-07-2020(online)].pdf | 2020-07-28 |
| 26 | 201721005626-Correspondence to notify the Controller [08-11-2021(online)].pdf | 2021-11-08 |
| 26 | 201721005626-FORM 3 [25-02-2020(online)].pdf | 2020-02-25 |
| 27 | 201721005626-Form 3-010319.pdf | 2020-01-14 |
| 27 | 201721005626-Written submissions and relevant documents [12-11-2021(online)].pdf | 2021-11-12 |
| 28 | 201721005626-Form 3-040919.pdf | 2019-11-02 |
| 28 | 201721005626-PRE GRANT OPPOSITION FORM [16-11-2021(online)].pdf | 2021-11-16 |
| 29 | 201721005626-FORM 3 [27-08-2019(online)].pdf | 2019-08-27 |
| 29 | 201721005626-PRE GRANT OPPOSITION DOCUMENT [16-11-2021(online)].pdf | 2021-11-16 |
| 30 | 201721005626-Correspondence--300719.pdf | 2019-08-01 |
| 30 | 201721005626-OTHERS [16-11-2021(online)].pdf | 2021-11-16 |
| 31 | 201721005626-Correspondence-300719.pdf | 2019-08-01 |
| 31 | 201721005626-FORM 3 [03-05-2022(online)].pdf | 2022-05-03 |
| 32 | 201721005626- ORIGINAL UR 6( 1A) FORM 26-110418.pdf | 2018-08-11 |
| 32 | 201721005626-FORM 3 [01-11-2022(online)].pdf | 2022-11-01 |
| 33 | 201721005626-Correspondence-181217.pdf | 2018-08-11 |
| 33 | 201721005626-FORM 3 [29-04-2023(online)].pdf | 2023-04-29 |
| 34 | 201721005626-Form 1-170217.pdf | 2018-08-11 |
| 34 | 201721005626-FORM 3 [11-10-2023(online)].pdf | 2023-10-11 |
| 35 | 201721005626-Form 2(Title Page)-170217.pdf | 2018-08-11 |
| 35 | 201721005626-PreGrant-HearingNotice-(HearingDate-12-04-2024).pdf | 2023-11-16 |
| 36 | 201721005626-PreGrant-ExtendedHearingNotice-(HearingDate-19-04-2024).pdf | 2024-03-21 |
| 36 | 201721005626-Form 3-170217.pdf | 2018-08-11 |
| 37 | 201721005626-POA [21-03-2024(online)].pdf | 2024-03-21 |
| 37 | 201721005626-Form 5-170217.pdf | 2018-08-11 |
| 38 | 201721005626-Other Patent Document-170217.pdf | 2018-08-11 |
| 38 | 201721005626-FORM 13 [21-03-2024(online)].pdf | 2024-03-21 |
| 39 | 201721005626-FORM 3 [02-07-2018(online)].pdf | 2018-07-02 |
| 39 | 201721005626-Correspondence to notify the Controller [03-04-2024(online)].pdf | 2024-04-03 |
| 40 | 201721005626-CORRESPONDENCE(IPO)-(CERTIFIED COPY)-(05-04-2018).pdf | 2018-04-05 |
| 40 | 201721005626-Correspondence to notify the Controller [16-04-2024(online)].pdf | 2024-04-16 |
| 41 | 201721005626-Written submissions and relevant documents [23-04-2024(online)].pdf | 2024-04-23 |
| 41 | 201721005626-FORM-26 [03-04-2018(online)].pdf | 2018-04-03 |
| 42 | 201721005626-ANY SUPPORTING DOCUMENT [23-04-2024(online)].pdf | 2024-04-23 |
| 42 | 201721005626-REQUEST FOR CERTIFIED COPY [30-03-2018(online)].pdf | 2018-03-30 |
Search Strategy
| 1 | SEARCHSTRATEGYE_26-03-2021.pdf |